Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
Institutionapricus wealth, LLC
Latest Disclosed Ownership5,764 shares
Latest Disclosed Value $ 591,779
apricus wealth, LLC ownership in ABL / Abbott Laboratories

On April 22, 2026 - apricus wealth, LLC filed a 13F-HR form disclosing ownership of 5,764 shares of Abbott Laboratories (DE:ABL) valued at $511,958 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 5,764 shares of Abbott Laboratories. This represents a change in shares of 0.00% during the quarter. The current value of the position is $433,568 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 5,764 0 0.00 592 -18.14 0.2884
2026-01-15 2025-12-31 13F ABBOTT LABS COM 002824100 5,764 43 0.75 722 -5.74 0.3688
2025-10-21 2025-09-30 13F ABBOTT LABS COM 002824100 5,721 247 4.51 766 2.96 0.4134
2025-07-30 2025-06-30 13F ABBOTT LABS COM 002824100 5,474 1 0.02 745 2.48 0.4329
2025-04-15 2025-03-31 13F ABBOTT LABS COM 002824100 5,473 879 19.13 726 39.88 0.4317
2025-01-21 2024-12-31 13F ABBOTT LABS COM 002824100 4,594 699 17.95 520 16.89 0.3372
2024-10-23 2024-09-30 13F ABBOTT LABS COM 002824100 3,895 -105 -2.62 444 6.99 0.2928
2024-07-25 2024-06-30 13F ABBOTT LABS COM 002824100 4,000 755 23.27 416 12.77 0.2968
2024-05-14 2024-03-31 13F ABBOTT LABS COM 002824100 3,245 71 2.24 369 5.44 0.2594
2024-01-22 2023-12-31 13F ABBOTT LABS COM 002824100 3,174 3,174 349 0.2662
2023-10-24 2023-09-30 13F ABBOTT LABS COM 002824100 0 -1,924 -100.00 0 -100.00
2023-07-20 2023-06-30 13F ABBOTT LABS COM 002824100 1,924 1,924 206 0.1810
2023-05-01 2023-03-31 13F ABBOTT LABS COM 002824100 0 -1,873 -100.00 0 -100.00
2023-01-31 2022-12-31 13F ABBOTT LABS COM 002824100 1,873 1,873 206 0.1872
2022-10-31 2022-09-30 13F ABBOTT LABS COM 002824100 0 -1,858 -100.00 0 -100.00
2022-08-12 2022-06-30 13F ABBOTT LABS COM 002824100 1,858 150 8.78 202 -3.35 0.1848
2022-04-21 2022-03-31 13F ABBOTT LABS COM 002824100 1,708 33 1.97 209 -11.44 0.1704
2022-03-09 2021-12-31 13F ABBOTT LABS COM 002824100 1,675 1,675 236 0.2106
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.